Search Results - "Cid, R. Pazo"

SEOM clinical guidelines for pancreatic and biliary tract cancer (2020) by Gómez-España, Mª A., Montes, A. F., Garcia-Carbonero, R., Mercadé, T. M., Maurel, J., Martín, A. M., Pazo-Cid, R., Vera, R., Carrato, A., Feliu, J.

“…Pancreatic cancer (PC) and biliary tract cancer (BTC) are both aggressive and highly fatal malignancies. Nowadays we have a profound knowledge about the…”
Get full text

The TEOGIC study project: a comprehensive characterization of early onset gastrointestinal cancer in the Northern area of Spain by Vera, R, Castro, N, Labiano, I, Lecumberri, A, Huerta, A E, Arasanz, H, Caseda, I, Ruiz-Pace, F, Viaplana, C, Arrazubi, V, Hernandez-Garcia, I, Mata, E, Gomez, D, Laguna, S, Suarez, J, Fernandez-De-Los-Reyes, I, Rullan, M, Estremera, F, Alonso, V, Pazo-Cid, R, Gil-Negrete, A, Lafuente, A, Martin-Carnicero, A, Dientsmann, R, Alsina, M

“…Gastrointestinal cancers represent one of the most prevalent diseases worldwide. Strikingly, the incidence of Early Onset Gastrointestinal Cancer (EOGIC) has…”
Get full text

Correction: the TEOGIC study project: a comprehensive characterization of early onset gastrointestinal cancer in the Northern area of Spain by Vera, R, Castro, N, Labiano, I, Lecumberri, A, Huerta, A E, Arasanz, H, Caseda, I, Ruiz-Pace, F, Viaplana, C, Arrazubi, V, Hernandez-Garcia, I, Mata, E, Gomez, D, Laguna, S, Suarez, J, Fernandez-De-Los-Reyes, I, Rullan, M, Estremera, F, Alonso, V, Pazo-Cid, R, Gil-Negrete, A, Lafuente, A, Martin-Carnicero, A, Dienstmann, R, Alsina, M

Get full text

SEOM clinical guideline on unknown primary cancer (2017) by Losa, F., Soler, G., Casado, A., Estival, A., Fernández, I., Giménez, S., Longo, F., Pazo-Cid, R., Salgado, J., Seguí, M. Á.

“…Cancer of unknown primary site is a histologically confirmed cancer that manifests in advanced stage, with no identifiable primary site following standard…”
Get full text

Novel antiangiogenic therapies against advanced hepatocellular carcinoma (HCC) by Pazo-Cid, R. A., Lanzuela, M., Esquerdo, G., Pérez-Gracia, J. L., Antón, A., Amigo, G., Trufero, J. Martínez, García-Otín, A. L., Martín-Duque, P.

“…Angiogenesis is a cornerstone in the process of hepatocarcinogenesis. In the sorafenib era, other antiangiogenic targeted drugs, such as monoclonal antibodies…”
Get full text

Carcinoma of unknown origin: Deep genomic profile helps to achieve an accurate diagnosis by Fernandez Díaz, A.B., Iranzo Gonzalez-Cruz, V., Cunquero Tomas, A.J., Avila Andrade, C., Jantus-Lewintre, E., Calabuig Fariñas, S., Ales, J.E., Valero, M., D'Errico, G., Pazo Cid, R.A., Gallego Martínez, A., Viana, A., Ponce Aix, S., Pérez-Fidalgo, J.A., Terradez, A., Rodrigo, A., Alvarez, L., Beniuga, G., Martorell, M., Camps, C.

Get full text

Biomarkers in pancreatic ductal adenocarcinoma by Gallego, J., López, C., Pazo-Cid, R., López-Ríos, F., Carrato, A.

“…Pancreatic ductal adenocarcinoma (PDAC) is currently the third most frequent form of malignancy. The role of biomarkers in the diagnostic and therapeutic…”
Get full text

Activity of weekly paclitaxel−cetuximab chemotherapy in unselected patients with recurrent/metastatic head and neck squamous cell carcinoma: prognostic factors by Bernad, I. Pajares, Trufero, J. Martínez, Urquizu, L. Calera, Pazo Cid, R. A., de Miguel, A. Cebollero, Agustin, M. J., Lanzuela, M., Antón, A.

“…Background Standard treatment for recurrent/metastatic head and neck squamous cell carcinoma (RM-SCCHN) is based in on platinum and cetuximab combination…”
Get full text

SEOM clinical guideline on unknown primary cancer (2017) by Losa, F., Soler, G., Casado, A., Estival, A., Fernández, I., Giménez, S., Longo, F., Pazo-Cid, R., Salgado, J., Seguí, M. Á.

Get full text

P-182 Multicenter real-world data of treatment with NALIRI plus 5FU/LV in advanced Spanish pancreatic cancer by Gallego, R. Álvarez, Cid, R. Pazo, López de San Vicente, B., Macarulla, T., Martinez de Castro, E., Goldaraz, F. Garicano, Granja, M., Ghanem, I., Martinez-Galán, J., Fernández, P. Ribera, Beveridge, R. Díaz, Valadés, J. Martín, Ángeles, C., Cubillo, A.

Get full text

6581 Von willebrand factor and fibrinogen levels predict outcome in advanced gastric cancer patients by Pazo-Cid, R, Godoy, A, Romera, J. Lao, Fernandez-Mosteirin, N, Puértolas, T, Calderero, V, García-Foncillas, R, Lucia, J.F, Lecumberri, M.J, Antón, A

Get full text

O-1 Liposomal irinotecan + 5-fluorouracil/leucovorin + oxaliplatin (NALIRIFOX) versus nab-paclitaxel + gemcitabine in treatment-naive patients with metastatic pancreatic ductal adenocarcinoma: Sensitivity analysis of survival from the NAPOLI 3 trial by Wainberg, Z., Melisi, D., Macarulla, T., Cid, R. Pazo, Chandana, S., Fouchardière, C. de la, Dean, A., Kiss, I., Lee, W., Goetze, T., Van Cutsem, E., Paulson, S., Bekaii-Saab, T., Pant, S., Hubner, R., Xiao, Z., Chen, H., Benzaghou, F., O'Reilly, E.

Get full text

nab-Paclitaxel (nab-P) plus gemcitabine (G) for patients (Pts) with locally advanced pancreatic cancer (LAPC): Interim efficacy and safety results from the Phase 2 LAPACT Trial by Philip, P.A., Lacy, J., Portales, F., Sobrero, A., Pazo-Cid, R., Manzano Mozo, J.L., Kim, E.S., Dowden, S., Zakari, A., Borg, C., Terrebonne, E., Rivera Herrero, F., Shiansong Li, J., Ong, T.J., Nydam, T., Hammel, P.

Get full text

Interim health related quality of life (QoL) from LAPACT, a Phase 2 trial of nab-paclitaxel (nab-P) plus gemcitabine (G) for patients (Pts) with locally advanced pancreatic cancer (LAPC) by Portales, F., Philip, P.A., Hammel, P., Buscaglia, M., Pazo-Cid, R., Manzano Mozo, J.L., Kim, E.S., Dowden, S., Zakari, A., Borg, C., Terrebonne, E., Rivera Herrero, F., Shiansong Li, J., Ong, T.J., Nydam, T., Lacy, J.

Get full text

A phase I and randomized phase II trial to evaluate the efficacy and safety of nab-paclitaxel (nab-P) in combination with gemcitabine (G) for the treatment of patients with ECOG 2 advanced pancreatic cancer (PDAC) by Hidalgo, M., Pazo-Cid, R., Guillen-Ponce, C., López, R., Vera, R., Reboredo, M., Muñoz, A., Martinez de Castro, E., Díaz Beveridge, R., La Casta, A., Martin-Valades, J.I., Cubillo, A., Martínez-Galán, J., Ales, I., Sastre, J., Macarulla Mercade, T.

Get full text

1860PCarcinoma of unknown origin: Deep genomic profile helps to achieve an accurate diagnosis by Fernandez Díaz, A B, Iranzo Gonzalez-Cruz, V, Cunquero Tomas, A J, Avila Andrade, C, Jantus-Lewintre, E, Calabuig Fariñas, S, Ales, J E, Valero, M, D'Errico, G, Pazo Cid, R A, Gallego Martínez, A, Viana, A, Ponce Aix, S, Pérez-Fidalgo, J A, Terradez, A, Rodrigo, A, Alvarez, L, Beniuga, G, Martorell, M, Camps, C

Get full text

YOSEMITE: A 3 arm double-blind randomized phase 2 study of gemcitabine, paclitaxel protein-bound particles for injectable suspension, and placebo (GAP) versus gemcitabine, paclitaxel protein-bound particles for injectable suspension and either 1 or 2 truncated courses of demcizumab (GAD) by Cubillo Gracian, A., Dean, A., Muñoz, A., Hidalgo, M., Pazo-Cid, R., Martin, M., Macarulla Mercade, T., Lipton, L., Harris, M., Manzano-Mozo, J.L., Maurel, J., Guillen-Ponce, C., Tebbutt, N., Cooray, P., Sohal, D., Zalupski, M., Kolevska, T., Stagg, R., Goldstein, D.

Get full text

Retrospective study of weekly paclitaxel-cetuximab (WPC) in unselected patients (p) with recurrent/metastatic head and neck squamous cell carcinoma (RM-SCCHN) by Bernad, I. Pajares, Trufero, J. Mártinez, Urquizu, L. Calera, de Miguel, A. Cebolleo, Cid, R. Pazo, Valero, M. Lanzuela, Agsustín, M.J., Millastre, E., Lobera, C. Santander, Alejandro, M. Alvarez, Gimeno, N., Yague, M. Malo, Llorente, Y., Torres, A. Antón

Get full text

Bevacizumab (BVZ) as second-line treatment after sorafenib (SFB) progression in patients (pts) with advanced hepatocellular carcinoma (HCC) by Pazo Cid, R. A., Esquerdo, G., Puertolas, T., Calderero, V., Gil, I., Lao, J., Millastre, E., Alvarez-Alejandro, M., Madani, J., Anton, A.

“…Abstract only…”
Get full text

Early response evaluation of sorafenib (SFB) therapy: Use of computed fluorodeoxiglucose positron emission tomography (PET-CT) in advanced hepatocellular carcinoma (HCC) by Lanzuela, M., Pazo Cid, R. A., Lao, J., Fuentes, J., Sarria, L., Horndler, C., Ubieto, MA, Puertolas, T., Calderero, V., Anton, A.

“…Abstract only…”
Get full text